Breast Cancer
Commentary
A Banned Chemical That Is Still Causing Cancer
This carcinogen ‘is still around: in our soil, in our food, and in our blood.’
From the Journals
Active Surveillance for Cancer Doesn’t Increase Malpractice Risk
Researchers identify malpractice trends involving active surveillance related to thyroid, prostate, kidney, and...
Feature
Women’s Cancers: Clinicians Research, Advise on Sexual Dysfunction
New research highlights the importance of discussing risks of sexual dysfunction in patients with women’s cancers.
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...
Latest News
New Transparent AI Predicts Breast Cancer 5 Years Out
The model works to predict risk based solely on “local bilateral dissimilarity.”
Feature
Look Beyond BMI: Metabolic Factors’ Link to Cancer Explained
A snapshot assessment of metabolic syndrome is inadequate to show an association with cancer risk over time, the authors of new research say.
Feature
Does worsening metabolic syndrome increase the risk of developing cancer?
Elevated trajectories of metabolic syndrome were associated with an elevated overall cancer risk.
Feature
Does Exercise Reduce Cancer Risk? It’s Just Not That Simple
What are the cancer types where exercise makes a difference?
Latest News
Study Finds No Increased Cancer Risk With Spironolactone
Spironolactone, used off-label for several skin conditions in women, carries a warning about an increased tumor risk associated with high doses in...
News from the FDA/CDC
First Denosumab Biosimilar Approved in Two Different Formulations
Denosumab-bddz was also granted interchangeability status, which allows pharmacists to substitute the biosimilar for the reference product without...
From the Journals
What Is the Long-Term Mortality Risk for Men With HR+ Breast Cancer?
Mortality risk in male patients showed different patterns over time than those seen in female patients.